UBP-302: Difference between revisions
Content deleted Content added
m date/fix the maintenance tags |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Orphan|date=November 2006}} |
{{Orphan|date=November 2006}} |
||
'''UBP-302''' is a highly selective [[Kainate]] receptor [[antagonist]] used in the study of many [[neurological]] processes. It is active at [[micromolar]] concentration within an ''[[in vitro]]'' preparation and specifically targets the [[GluR5]] subunit of the receptor. It has only been recently made commercially available through such companies as [ |
'''UBP-302''' is a highly selective [[Kainate]] receptor [[antagonist]] used in the study of many [[neurological]] processes. It is active at [[micromolar]] concentration within an ''[[in vitro]]'' preparation and specifically targets the [[GluR5]] subunit of the receptor. It has only been recently made commercially available through such companies as [http://www.tocris.com/dispprod.php?ItemId=103553 Tocris]. |
||
UPB-302 is useful in the study of neuronal [[up-states]]. |
UPB-302 is useful in the study of neuronal [[up-states]]. |
||
Revision as of 15:18, 23 November 2007
UBP-302 is a highly selective Kainate receptor antagonist used in the study of many neurological processes. It is active at micromolar concentration within an in vitro preparation and specifically targets the GluR5 subunit of the receptor. It has only been recently made commercially available through such companies as Tocris.
UPB-302 is useful in the study of neuronal up-states.
.svg){kind=small} | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
